The Genetics Epidemic: The Revolution in DNA Science -- And What To Do About It
By Jamie F. Metzl,
Foreign Affairs
| 10. 12. 2014
Untitled Document
The revolution in genetic engineering that will make it possible for humans to actively manage our evolutionary process for the first time in our species’ history is already under way. In laboratories and clinics around the world, gene therapies are being successfully deployed to treat a range of diseases, including certain types of immune deficiency, retinal amaurosis, leukemia, myeloma, hemophilia, and Parkinson’s. This miraculous progress is only the beginning. The same already existing technologies that will soon eliminate many diseases that have victimized humans for thousands of years will almost certainly be used eventually to make our species smarter, stronger, and more robust.
The prospect of genetic engineering will be exciting to some, frightening to others, and challenging for all. If not adequately addressed, it will also likely lead to major conflict both within societies and globally. But although the science of human genetic engineering is charging forward at an exponential rate, the global policy framework for ensuring this scientific progress does not lead to destabilizing conflict barely exists at all. The time has come for a meaningful...
Related Articles
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...